- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 253
Cover covets corporates in $16m series B
Exor and Samsung Ventures both chipped in as the mobile insurance brokerage boosted its overall funding to $27m.
Oct 3, 2018Mumzworld takes care with $20m round
Tamer and Twofour54-backed Mumzworld plans to use Gulf Islamic Investments' series B funding to expand its e-commerce platform in Saudi Arabia.
Oct 3, 2018Human Inc heads to $21m series B
Microsoft has invested in consumer technology developer Human, Incorporated's series B round, which was co-led by Sage Venture Partners, Ropart Asset Management and Sugar Mountain Capital.
Oct 3, 2018Pivot Bio reaps $70m in series B funding
Monsanto-backed Pivot Bio has now raised a total of almost $87m and will use the latest funding to develop its second crop nutrition product.
Oct 3, 2018M12 drives Netradyne's series B to $21m
Reliance Industries returned to invest $8m in an M12-led round that took Netradyne's funding to $37m in just over two years.
Oct 3, 2018Shopal shuts series B-plus round
The luxury branding services provider raised $29.2m in a round led by Youngor Group that included existing investor Cathay Capital Private Equity.
Oct 2, 2018Pymetrics picks out corporates to raise $40m
Recruitment analytics technology provider Pymetrics has closed a series B round featuring Salesforce Ventures and returning investor Workday Ventures.
Oct 2, 2018Gilmour Space thrusts $13.7m into orbit
Satellite launching rocket producer Gilmour Space Technologies has been backed by Main Sequence Ventures, managers of Csiro Innovation Fund, taking its total to $17.4m.
Oct 1, 2018Corporate venturing deal net: 24-28 September 2018
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Sep 28, 2018Morphic shapes $80m series B
Novo has co-led a series B round together with Omega Funds for Morphic Therapeutic, based on research by Harvard professor Timothy Springer.
Sep 28, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


